the addition of a prostaglandin synthetase inhibitor , naproxen , was found to afford pain relief to a further 70 % of women with oc-resistant dysmenorrhea in a double-blind cross-over study comprising 39 patients .
C0027396
naproxen
C0013390
dysmenorrhea